NCT05762731 Screening for Lung Cancer in Subjects With Family History of Lung Cancer
| NCT ID | NCT05762731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,520 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,520 participants in total. It began in 2023-02-01 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDCT screening for lung cancer. In Hong Kong, however, there is a prominence of female never-smokers with lung cancer. There is no identifiable risk factors for non-smokers with lung cancer except family history of lung cancer. The hypothesis is that lung cancer screening for subjects with family history of lung cancer, can detect early lung cancer.
Eligibility Criteria
Inclusion Criteria: * Age 50-75, men or women, smokers or non-smokers * Being first degree relatives (Siblings, children, and parents) of lung cancer subjects * Having no known lung cancer before Exclusion Criteria: * Non-Chinese * Mentally incompetent to give informed consent
Frequently Asked Questions
Who can join the NCT05762731 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05762731 currently recruiting?
Yes, NCT05762731 is actively recruiting participants. Visit ClinicalTrials.gov or contact The University of Hong Kong to inquire about joining.
Where is the NCT05762731 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT05762731 clinical trial?
NCT05762731 is sponsored by The University of Hong Kong. The trial plans to enroll 1,520 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.